Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that its management team will present at the following investor conferences:

• 2023 Wells Fargo Healthcare Conference
  
  
  
  Presenting via fireside chat on Wednesday, September 6, 2023 at 3:00 p.m. Eastern Time in Boston, MA at the Encore Boston Harbor
  
  
  
  
• Morgan Stanley 21^st Annual Global Healthcare Conference
  
  
  
  Presenting via fireside chat on Monday, September 11, 2023 at 2:55 p.m. Eastern Time in New York, NY at the Sheraton New York

The live audio webcasts and replays of the presentations may be accessed on the “Investor Relations” section of the company’s website at: https://cuehealth.com/.

About Cue Health

Cue Health Inc. (Nasdaq: HLTH) is a healthcare technology company that uses diagnostic-enabled care to empower people to live their healthiest lives. The Cue Health platform offers individuals and healthcare providers convenient and personalized access to lab-quality diagnostic tests at home and at the point of care, as well as on-demand telehealth consultations and treatment options for a wide range of health and wellness needs. Cue’s customers include federal and state public sector agencies and the private sector, which includes healthcare providers, enterprises, and individual consumers. Cue’s COVID-19 test was the first FDA-authorized molecular diagnostic test for at-home and over-the-counter use without a prescription. Cue has since received Emergency Use Authorization from the FDA for its molecular mpox test at the point of care and, to expand its test menu, the company has a number of other submissions under review by the FDA. Cue, founded in 2010, owns over 100 patents and is headquartered in San Diego. For more information, please visit www.cuehealth.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230823775661/en/